Figures & data
Figure 1. Measurement of the effect of KD025 on adipogenesis in hADSCs.
![Figure 1. Measurement of the effect of KD025 on adipogenesis in hADSCs.](/cms/asset/9a780726-5a93-4a90-ba9f-42da4a86d675/kadi_a_1590929_f0001_oc.jpg)
Table 1. List of real time PCR primers and sequences.
Figure 2. Effect of KD025 on fate determination of human stem cells.
![Figure 2. Effect of KD025 on fate determination of human stem cells.](/cms/asset/18856172-e926-4477-91cd-7c6f54bdc46e/kadi_a_1590929_f0002_oc.jpg)
Figure 3. Effect of KD025 on adipogenic and lipogenic markers.
![Figure 3. Effect of KD025 on adipogenic and lipogenic markers.](/cms/asset/ed625f85-a582-4d7c-996d-93dab6dc0df5/kadi_a_1590929_f0003_oc.jpg)
Figure 4. Stage-specific effect of KD025 on adipogenesis of hADSC.
![Figure 4. Stage-specific effect of KD025 on adipogenesis of hADSC.](/cms/asset/b39559a2-0784-43ea-b7bb-11c6a29d7f49/kadi_a_1590929_f0004_oc.jpg)
Figure 5. Effects of ROCK inhibitors on insulin signaling.
![Figure 5. Effects of ROCK inhibitors on insulin signaling.](/cms/asset/7d81142a-157d-457b-9c42-90301deb11ca/kadi_a_1590929_f0005_oc.jpg)
Figure 6. Effects of ROCK inhibitors on adipogenesis of hADSCs.
![Figure 6. Effects of ROCK inhibitors on adipogenesis of hADSCs.](/cms/asset/8d553c93-7ff2-4285-a0ef-3cd1ff7efe06/kadi_a_1590929_f0006_oc.jpg)
Figure 7. Proposed model of the mechanistic action of KD025 on the differentiation of hADSCs.
![Figure 7. Proposed model of the mechanistic action of KD025 on the differentiation of hADSCs.](/cms/asset/2385c979-7bdb-4fd2-99fe-161f79e08ba8/kadi_a_1590929_f0007_oc.jpg)